CL2016002499A1 - Nuevo uso de n,n - bis-2-mercaptoetil isoftalamida - Google Patents

Nuevo uso de n,n - bis-2-mercaptoetil isoftalamida

Info

Publication number
CL2016002499A1
CL2016002499A1 CL2016002499A CL2016002499A CL2016002499A1 CL 2016002499 A1 CL2016002499 A1 CL 2016002499A1 CL 2016002499 A CL2016002499 A CL 2016002499A CL 2016002499 A CL2016002499 A CL 2016002499A CL 2016002499 A1 CL2016002499 A1 CL 2016002499A1
Authority
CL
Chile
Prior art keywords
bis
copd
new use
morbility
risk
Prior art date
Application number
CL2016002499A
Other languages
English (en)
Inventor
Boyd Eugene Haley
Ragnar Axel Theodor Klingberg
Original Assignee
Emeramed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50776843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016002499(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Emeramed Ltd filed Critical Emeramed Ltd
Publication of CL2016002499A1 publication Critical patent/CL2016002499A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

<p>USO DE N,N- BIS-2-MERCAPTOETIL ISOFTALAMIDA PARA TRATAR LA ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA (EPOC), AUMENTAR LOS NIVELES DE ASCORBATO Y REDUCIR EL RIESGO DE MORBILIDAD Y/O MORTALIDAD RESPIRATORIA; PROCEDIMIENTO PARA TRATAR LA EPOC, REDUCIR EL RIESGO DE MORBILIDAD <em>Y/O </em>MORTALIDAD RESPIRATORIA Y ALIVIAR SINTOMAS DE LA EPOC.</p>
CL2016002499A 2014-04-04 2016-09-30 Nuevo uso de n,n - bis-2-mercaptoetil isoftalamida CL2016002499A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1406115.4A GB2524831A (en) 2014-04-04 2014-04-04 New pharmaceutical use

Publications (1)

Publication Number Publication Date
CL2016002499A1 true CL2016002499A1 (es) 2017-01-27

Family

ID=50776843

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016002499A CL2016002499A1 (es) 2014-04-04 2016-09-30 Nuevo uso de n,n - bis-2-mercaptoetil isoftalamida

Country Status (35)

Country Link
US (1) US9782368B2 (es)
EP (1) EP3125876B8 (es)
JP (1) JP6474423B2 (es)
KR (1) KR102482699B1 (es)
CN (1) CN106132405B (es)
AU (1) AU2015242374B2 (es)
BR (1) BR112016022880B1 (es)
CA (1) CA2944113C (es)
CL (1) CL2016002499A1 (es)
CY (1) CY1121235T1 (es)
DK (1) DK3125876T3 (es)
EA (1) EA032116B1 (es)
EC (1) ECSP16078100A (es)
ES (1) ES2659174T3 (es)
GB (1) GB2524831A (es)
HR (1) HRP20180325T1 (es)
HU (1) HUE036206T2 (es)
IL (1) IL248027B (es)
LT (1) LT3125876T (es)
MA (1) MA39833B1 (es)
ME (1) ME03012B (es)
MX (1) MX2016012591A (es)
NO (1) NO3125876T3 (es)
NZ (1) NZ724678A (es)
PE (1) PE20170586A1 (es)
PH (1) PH12016501975A1 (es)
PL (1) PL3125876T3 (es)
PT (1) PT3125876T (es)
RS (1) RS56905B1 (es)
SA (1) SA516371966B1 (es)
SG (1) SG11201607478RA (es)
SI (1) SI3125876T1 (es)
UA (1) UA119558C2 (es)
WO (1) WO2015150793A1 (es)
ZA (1) ZA201606406B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7201989B2 (ja) 2018-10-22 2023-01-11 株式会社松井製作所 粉粒体材料の貯留装置
GB202005057D0 (en) 2020-04-06 2020-05-20 Emeramed Ltd New Use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586600B2 (en) 2000-12-06 2003-07-01 University Of Kentucky Research Foundation Multidentate sulfur-containing ligands
JP2011026204A (ja) * 2007-11-26 2011-02-10 Rei Furukawa タバコの煙を吸入することにより引き起こされる疾患の予防及び／又は治療用組成物
US8950583B2 (en) * 2008-12-06 2015-02-10 Ermes Medical Company Limited Method to remove heavy metals from a mammal
IN2012DN02586A (es) 2009-09-28 2015-08-28 Univ Kentucky Res Found
US8575218B2 (en) 2009-09-28 2013-11-05 The University Of Kentucky Research Foundation Thiol-containing compounds for the removal of elements from tissues and formulations therefor
US8426368B2 (en) 2010-03-25 2013-04-23 The University Of Kentucky Research Foundation Method of ameliorating oxidative stress and supplementing the diet
US20110237776A1 (en) 2010-03-25 2011-09-29 Haley Boyd E Aromatic compounds with sulfur containing ligands

Also Published As

Publication number Publication date
NZ724678A (en) 2022-12-23
ZA201606406B (en) 2018-04-25
ECSP16078100A (es) 2018-03-31
WO2015150793A1 (en) 2015-10-08
SI3125876T1 (en) 2018-04-30
LT3125876T (lt) 2018-02-12
UA119558C2 (uk) 2019-07-10
RS56905B1 (sr) 2018-05-31
ME03012B (me) 2018-10-20
US20170157072A1 (en) 2017-06-08
MA39833B1 (fr) 2018-04-30
EP3125876B1 (en) 2017-11-29
CN106132405B (zh) 2019-06-18
PT3125876T (pt) 2018-02-22
MA39833A (fr) 2017-02-08
PL3125876T3 (pl) 2018-05-30
CN106132405A (zh) 2016-11-16
JP2017511307A (ja) 2017-04-20
PH12016501975A1 (en) 2017-01-09
EA201692013A1 (ru) 2017-03-31
GB2524831A (en) 2015-10-07
HUE036206T2 (hu) 2018-06-28
PE20170586A1 (es) 2017-05-20
NO3125876T3 (es) 2018-04-28
EA032116B1 (ru) 2019-04-30
BR112016022880B1 (pt) 2022-09-13
AU2015242374A1 (en) 2016-10-13
HRP20180325T1 (hr) 2018-04-06
EP3125876A1 (en) 2017-02-08
US9782368B2 (en) 2017-10-10
ES2659174T3 (es) 2018-03-14
EP3125876B8 (en) 2018-01-24
AU2015242374B2 (en) 2019-10-10
KR102482699B1 (ko) 2022-12-28
CA2944113A1 (en) 2015-10-08
CA2944113C (en) 2022-06-21
DK3125876T3 (en) 2018-01-15
JP6474423B2 (ja) 2019-02-27
BR112016022880A2 (es) 2017-08-15
GB201406115D0 (en) 2014-05-21
SG11201607478RA (en) 2016-10-28
CY1121235T1 (el) 2020-05-29
IL248027B (en) 2019-03-31
MX2016012591A (es) 2017-04-06
SA516371966B1 (ar) 2019-04-14
KR20160140929A (ko) 2016-12-07

Similar Documents

Publication Publication Date Title
CL2016001889A1 (es) (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1.
DOP2015000246A (es) Derivados de oxopiridina sustituida y usos de los mismos en el tratamiento de trastornos cardiovasculares
EA201691594A1 (ru) Циклопропиламины в качестве ингибиторов lsd1
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
CR20150337A (es) Derivados de pirimidinona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral
EA201790266A1 (ru) Индолы для применения при инфекции, вызванной вирусом гриппа
UA118558C2 (uk) Пептидна сполука
CL2016001543A1 (es) Derivados del isocromeno como inhibidores de las fosfoinositido-3 quinasas.
CL2016000190A1 (es) Polipéptidos cíclicos para el tratamiento de la insuficiencia cardiaca.
MD3500241T2 (ro) Terapie combinată pentru BPOC
NI201500175A (es) Compuestos nuevos para el tratamiento del cáncer
CR20150496A (es) Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a
DOP2017000014A (es) Métodos para mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
CL2015000537A1 (es) Siarn y su uso en los métodos y composiciones para el tratamiento y/o prevención de enfermedades de los ojos.
CR20160529A (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
CL2014001127A1 (es) Metodos y composicion de fumigante que comprende hexafluoropropeno, 1,1,3,3,3-pentafluoropropeno o combinacion de los mismos.
CL2020000812A1 (es) Semaglutida en la terapia médica.
EA201791099A1 (ru) Хинолин карбоксамиды для применения в лечении лейкоза
CL2016002499A1 (es) Nuevo uso de n,n - bis-2-mercaptoetil isoftalamida
CU20150176A7 (es) Derivados de prodroga de triazolpiridinas sustituídas
KR102230908B9 (ko) 복합형 저녹스 버너
EA201501130A1 (ru) Офтальмологическая фармацевтическая композиция
BR112016028081A2 (pt) Novos compostos como agentes antituberculares
UY34752A (es) Agentes para el control de la chinche del eucalipto